NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Up 57.7% in February

NewGenIvf Group Limited (NASDAQ:NIVFGet Free Report) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 184,500 shares, an increase of 57.7% from the February 13th total of 117,000 shares. Based on an average trading volume of 1,200,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 79.0% of the company’s shares are sold short.

Institutional Investors Weigh In On NewGenIvf Group

An institutional investor recently raised its position in NewGenIvf Group stock. XTX Topco Ltd increased its stake in shares of NewGenIvf Group Limited (NASDAQ:NIVFFree Report) by 400.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,801 shares of the company’s stock after buying an additional 59,059 shares during the quarter. XTX Topco Ltd owned 0.73% of NewGenIvf Group worth $30,000 at the end of the most recent quarter. Institutional investors and hedge funds own 66.24% of the company’s stock.

NewGenIvf Group Price Performance

NIVF traded up $0.01 during trading on Friday, hitting $1.07. The company’s stock had a trading volume of 259,248 shares, compared to its average volume of 470,824. NewGenIvf Group has a twelve month low of $0.94 and a twelve month high of $65.60. The stock’s fifty day moving average price is $3.67 and its 200-day moving average price is $9.63.

NewGenIvf Group Company Profile

(Get Free Report)

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.

Recommended Stories

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.